Changes in IL-6, IL-8, C-reactive protein and pancreatic secretory trypsin inhibitor after transcatheter arterial chemo-embolization therapy for hepato-cellular carcinoma-Reference-Cited by-同舟云学术

Changes in IL-6, IL-8, C-reactive protein and pancreatic secretory trypsin inhibitor after transcatheter arterial chemo-embolization therapy for hepato-cellular carcinoma

Published:1992-11 Issue:6 Volume:4 Page:581-584
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Ikei Satoshi,Ogawa Michio,Beppu Toru,Ohara Chitoshi,Sakamoto Kiyoshi,Sameshima Hirofumi,Arakawa Hirohumi,Yamaguchi Yasuo,Yamanaka Tsuyoshi,Kudo Shunsuke,Matsushima Kouji

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference17 articles.

1. Multiple actions of interleukin 6 within a cytokine network;Wong;Immunol Today,1988

2. Recombinant human B cell stimulatory factor 2 (BSF-2/IFNb2) regulates b-fibrinogen and albumin mRNA levels in Fao-9 cells;Andus;FEBS Lett,1987

3. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis;Leser;Gastroenterology,1991

4. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer;Fearon;Ann Surg,1991

5. The serum interleukin 6 response to elective surgery;Shenkin;Lymphokine Res,1988

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Strategies for Gastrointestinal Cancer: HCC;Immune Strategies for Gastrointestinal Cancer;2023

2. Efficacy and Safety of Percutaneous Argon-Helium Cryoablation for Hepatocellular Carcinoma Abutting the Diaphragm;Journal of Vascular and Interventional Radiology;2020-03

3. Liver and Bile Duct Cancer;Abeloff's Clinical Oncology;2020

4. Ablative Techniques for CRLM: Alone or in Association;Colorectal Cancer Liver Metastases;2019-12-29

5. Immune Checkpoint Inhibitors in Gastrointestinal Malignancies;Immune Checkpoint Inhibitors in Cancer;2019